These Patients Had to Lobby for Correct Diabetes Diagnoses. Was Their Race a Reason?

Adults who develop one autoimmune form of diabetes are often misdiagnosed with Type 2 diabetes. Those wrong diagnoses make it harder to get the appropriate medications and technology to manage their blood sugar. Many Black patients wonder if their race plays a role.

Patients With Narcolepsy Face a Dual Nightmare of Medication Shortages and Stigma

It’s been more than a year since the FDA declared a national shortage of Adderall, and it’s affecting more than just patients with ADHD. Those with narcolepsy, a much rarer condition, are often treated with the same medication. Without it, they’re often unable to drive or function as usual.

Mental Health Courts Can Struggle to Fulfill Decades-Old Promise

Mental health courts have been touted as a means to help reduce the flow of people with mental illness into jails and prisons. But the specialized diversion programs can struggle to live up to that promise, and some say they’re a bad investment.

‘AGGA’ Inventor Testifies His Dental Device Was Not Meant for TMJ or Sleep Apnea

The FDA and Department of Justice are investigating the Anterior Growth Guidance Appliance, or “AGGA.” TMJ and sleep apnea patients have filed lawsuits alleging the device harmed them. Its inventor now says the AGGA was never meant for these ailments.

The Year in Opioid Settlements: 5 Things You Need to Know

In the past year, opioid settlement money has gone from an emerging funding stream for which people had lofty but uncertain aspirations to a coveted pot of billions being invested in remediation efforts. Here are some important and evolving factors to watch going forward.

‘I Am Just Waiting to Die’: Social Security Clawbacks Drive Some Into Homelessness

The Social Security Administration is reclaiming billions of dollars in alleged overpayments from some of the nation’s poorest and most vulnerable, leaving some people homeless or struggling to stay in housing, beneficiaries and advocates say.

‘They See a Cash Cow’: Corporations Could Consume $50 Billion of Opioid Settlements

As opioid settlement dollars land in government coffers, a swarm of businesses are positioning themselves to profit from the windfall. But will their potential gains come at the expense of the settlements’ intended purpose — to remediate the effects of the opioid epidemic?

As Foundation for ‘Excited Delirium’ Diagnosis Cracks, Fallout Spreads

Major policy changes and disavowals have made this a watershed year for curbing the use of the discredited “excited delirium” diagnosis to explain deaths in police custody. Now the ripple effects are spreading across the country into court cases, state legislation, and police training classes.

Candidates Clashed But Avoided Talk of Abortion at 4th GOP Primary Debate

Obamacare had its moment, but not until the faceoff’s final minutes. Front-runner Donald Trump again was not on the debate stage, leaving the other Republican presidential hopefuls to slug it out to break through and gain voters’ attention.